After new rumors ensued about the possible Johnson & Johnson takeover of Smith & Nephew, the latter company's stock prices soared and it became the top riser in the FTSE 100 this past Wednesday, according to a Wall Street Journal report.
Last January, the company experienced a similar boost when speculation of a takeover ran rampant. However, Smith & Nephew executives maintained the rumors were false. Instead, Johnson & Johnson took over Synthes, a Swiss device company.
Other large orthopedic device companies, such as Biomet, have been considered possible suitors for Smith & Nephew as well.
Related Articles on Orthopedic Device Companies:
Stryker Accesses Stroke Market With Concentric Medical Acquisition
Former DePuy President David Floyd Becomes CEO of OrthoWorx
Patent Infringement Trial Underway for Medtronic and NuVasive
Other large orthopedic device companies, such as Biomet, have been considered possible suitors for Smith & Nephew as well.
Related Articles on Orthopedic Device Companies:
Stryker Accesses Stroke Market With Concentric Medical Acquisition
Former DePuy President David Floyd Becomes CEO of OrthoWorx
Patent Infringement Trial Underway for Medtronic and NuVasive